Northeast Financial Consultants’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,913
| Closed | -$312K | – | 279 |
|
|
2024
Q1 | $312K | Buy |
+3,913
| New | +$299K | 0.02% | 235 |
|
|
2022
Q4 | – | Sell |
-6,006
| Closed | -$573K | – | 328 |
|
|
2022
Q3 | $573K | Hold |
6,006
| – | – | 0.04% | 171 |
|
|
2022
Q2 | $557K | Hold |
6,006
| – | – | 0.04% | 179 |
|
|
2022
Q1 | $608K | Hold |
6,006
| – | – | 0.04% | 202 |
|
|
2021
Q4 | $620K | Hold |
6,006
| – | – | 0.04% | 196 |
|
|
2021
Q3 | $510K | Hold |
6,006
| – | – | 0.03% | 221 |
|
|
2021
Q2 | $501K | Hold |
6,006
| – | – | 0.03% | 224 |
|
|
2021
Q1 | $452K | Buy |
6,006
+133
| +2% | +$9.69K | 0.03% | 221 |
|
|
2020
Q4 | $401K | Hold |
5,873
| – | – | 0.03% | 222 |
|
|
2020
Q3 | $343K | Sell |
5,873
-32
| -0.5% | -$1.99K | 0.03% | 214 |
|
|
2020
Q2 | $384K | Buy |
5,905
+19
| +0.3% | +$1.2K | 0.04% | 194 |
|
|
2020
Q1 | $349K | Buy |
5,886
+1,306
| +29% | +$87.2K | 0.04% | 190 |
|
|
2019
Q4 | $340K | Sell |
4,580
-54
| -1% | -$3.79K | 0.03% | 221 |
|
|
2019
Q3 | $292K | Sell |
4,634
-32
| -0.7% | -$1.9K | 0.03% | 248 |
|
|
2019
Q2 | $254K | Hold |
4,666
| – | – | 0.03% | 263 |
|
|
2019
Q1 | $252K | Sell |
4,666
-14,200
| -75% | -$876K | 0.03% | 261 |
|
|
2018
Q4 | $1.24M | Buy |
+18,866
| New | +$1.41M | 0.17% | 87 |
|
|
2017
Q4 | – | Sell |
-7,849
| Closed | -$638K | – | 155 |
|
|
2017
Q3 | $638K | Buy |
7,849
+449
| +6% | +$35.5K | 0.23% | 74 |
|
|
2017
Q2 | $595K | Sell |
7,400
-1,000
| -12% | -$79K | 0.23% | 77 |
|
|
2017
Q1 | $659K | Sell |
8,400
-700
| -8% | -$55.9K | 0.28% | 65 |
|
|
2016
Q4 | $718K | Buy |
9,100
+3,300
| +57% | +$267K | 0.32% | 57 |
|
|
2016
Q3 | $504K | Buy |
5,800
+800
| +16% | +$75.5K | 0.21% | 80 |
|
|
2016
Q2 | $479K | Hold |
5,000
| – | – | 0.21% | 82 |
|
|
2016
Q1 | $519K | Hold |
5,000
| – | – | 0.27% | 68 |
|
|
2015
Q4 | $489K | Hold |
5,000
| – | – | 0.25% | 69 |
|
|
2015
Q3 | $482K | Hold |
5,000
| – | – | 0.24% | 77 |
|
|
2015
Q2 | $524K | Hold |
5,000
| – | – | 0.23% | 81 |
|
|
2015
Q1 | $516K | Buy |
5,000
+1,200
| +32% | +$121K | 0.23% | 79 |
|
|
2014
Q4 | $366K | Sell |
3,800
-55
| -1% | -$4.85K | 0.19% | 88 |
|
|
2014
Q3 | $307K | Hold |
3,855
| – | – | 0.17% | 101 |
|
|
2014
Q2 | $290K | Buy |
+3,855
| New | +$291K | 0.16% | 95 |
|
Other funds holding CVS
Northeast Financial Consultants's CVS Position: Q2 2024 in Review
Northeast Financial Consultants sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,913 shares — an estimated $312K sold.
Northeast Financial Consultants first reported a position in CVS in Q2 2014 and held it in 31 quarters. The position peaked at $1.24M in Q4 2018. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Northeast Financial Consultants reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Northeast Financial Consultants sold 3,913 CVS Health shares in Q2 2024, an estimated $312K.
- Northeast Financial Consultants first reported a position in CVS Health in Q2 2014 and held it in 31 quarters.
- Northeast Financial Consultants's CVS Health position peaked at $1.24M in Q4 2018.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Northeast Financial Consultants's 13F filing for Q2 2024, filed 15 Aug 2024.